Metabolic consequences of recombinant human growth hormone therapy in patients with Turner syndrome

INTRODUCTION: Turner syndrome (TS) predisposes to metabolic complications. Currently, TS patients are treated with recombinant human growth hormone (rGH) as standard therapy. The long-term effect of this therapy on carbohydrate metabolism remains unclear. AIM OF THE STUDY: To assess possible metabol...

Descripción completa

Detalles Bibliográficos
Autores principales: Gnacińska, Maria, Magnuszewska, Hanna, Sworczak, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original paper | Praca oryginalna
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226455/
https://www.ncbi.nlm.nih.gov/pubmed/36734396
http://dx.doi.org/10.5114/pedm.2022.123204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226455/
https://www.ncbi.nlm.nih.gov/pubmed/36734396
http://dx.doi.org/10.5114/pedm.2022.123204

Ejemplares similares